Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : URMD -- Huge market potential -- Ignore unavailable to you. Want to Upgrade?

To: Samuel J. Bennett who wrote (196)	1/19/1998 12:47:00 PM
From: Hugh A. McWhorter	Respond to of 369

Sam--betting with the house is always a good idea and the debt that was issued was probably a good investment. Unfortunately I was never offered any <g>. Debt as URMD has issued has priority in cash flow and, heaven forbid, liquidation. Add a conversion feature and it's even more attractive. Seems like the big boys can always get in a better position than the little guy like me. After studying the financials and reflecting on this one I am personally going to wait for some numbers before altering my modest holdings and put sales. Best regards. Hugh

To: Samuel J. Bennett who wrote (196)	1/24/1998 5:12:00 PM
From: Hugh A. McWhorter	Read Replies (1) \| Respond to of 369

Ain't self imposed disciplines great? With the further drifting south of the stock I could not resist the temptation to acquire a few hundred more shares and did so. Sure hope Individual Investor is right. Hugh

To: Samuel J. Bennett who wrote (196)	2/18/1998 3:51:00 PM
From: Hugh A. McWhorter	Read Replies (1) \| Respond to of 369

Sam--after reading the most recent quarterly financial statements I figured it was time to call investors relations. Here's what I was told by Kristen Galfetti, Investors Relations. --revenues for the entire year will be less than $2 million which means that significant losses will continue for the remainder of the year --all of the brokerage firms who follow URMD have a "hold" on the stock. At my request, Kristen gave me the names of two analysts who follow URMD (Dain Bosworth--Parice Halbert #612-371-2916 and Paine Weber Dave Lawson #212-713-2442). If anyone wants to call either or both of these gentlemen I would appreciate hearing what they say. At the moment I am buried with work. --URMD has ceased trying to sell their incontenience products and is seeking a large affiliation. One company (Kristen would not say who) has approached them about an alliance. Kristen stated that a 6 month time frame would be a reasonable amount of time for a relationship to develop. This will be the revenue creator--1999 at the earliest. --she believes the worst case scenario has been presented to the public and shareholders and mentioned that both she and her father are shareholders. --she explained the cavermat (prostrate cancer) at great length and advises that one of the world's foremost urologists--a Dr. Pat Walsh has announced he will commence using it. --the convertible securities all bear interest at 6% and mature in 2003. They are convertible at a rate of $13.28 per share. (I would have to believe these are trading at a discount). --they do not release back log information. --she mentioned that the Reliance Mutual fund has a large position in the company. --as of the end of the year 1 million shares have been shorted. (Company has in excess of 26 million outstanding) --revenues of the past have almost exclusively been related to foreign sales and will be non recurring. After listening to her I decided to do nothing which I guess translates to the hold recommendation. Any thoughts to add? Hugh

To: Samuel J. Bennett who wrote (196)	6/13/1998 1:38:00 PM
From: Hugh A. McWhorter	Read Replies (1) \| Respond to of 369

Sam-for a number of months (6???) you have been conspicuous by the absence of your posts. I assume you were one of the wise investors who dumped this one. True? I do miss your posts on URMD as it was quite apparent that you were a "seasoned" investor. I need some encouragement on URMDD as they seem to be constantly announcing some new product but never announcing any sales. Any encouragement to offer? If not what are you into now? I have been shorting puts on Cott (I thought they would be acquired and straddling SUNW--marvelous put and call premiums but you have to watch it like a hawk). Hugh